Back

Effectiveness and safety of direct oral anticoagulants versus vitamin k antagonists in patients with atrial fibrillation and hypertrophic cardiomyopathy: a systematic review and meta-analysis

1 September 2025 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Anticoagulation pharmacotherapy updates Anticoagulants ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Kaue Chagas

Itaperuna (Brazil)

4 More presentations in this session

Presentation thumbnail
LOw-dose RAbeprazole therapy for reducing gastrointestinal events in patients with High Bleeding Risk (LORA-HBR): a prospective, multicenter, interventional study
Assistant Professor E. Park (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Trends and outcomes of direct oral anticoagulant use in patients with cancer: a nationwide cohort study
Doctor A. Holt (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Long-term outcomes of direct oral anticoagulants versus warfarin for chronic thromboembolic pulmonary hypertension: a reconstructed individual patient data meta-analysis
Doctor A. Chng (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
The efficacy and safety of direct oral anticoagulants compared to warfarin for LV thrombus resolution
Doctor S. Azevedo (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Anticoagulation pharmacotherapy updates

The Event

Event poster

ESC Congress 2025

1 September 2025 10:15 CET
You may be interested in
thumbnail
Congress Presentation
The efficacy and safety of direct oral anticoagulants compared with vitamin K antagonist in patients with hypertrophic cardiomyopathy and atrial fibrillation: a systematic review and meta-analysis
thumbnail
Congress Presentation
Anticoagulation strategy of choice for atrial fibrillation ablation - a network meta-analysis of complication rates
thumbnail
Congress Presentation
Direct oral anticoagulants versus vitamin k antagonists in patients with atrial fibrillation and bioprosthesis: a systematic review and meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources